CLINICAL_TRIALS
trial_result
· 2026-04-02
Clinical Trial Update: Roll-over Study to Allow Continued Access to Ribociclib [Phase 4]
Summary
A Phase 4 roll-over study provides continued access to ribociclib for patients with metastatic breast cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Metastatic Breast Cancer | Phase 4 | Status: ACTIVE_NOT_RECRUITING